Nabriva Therapeutics plc
Healthcare · Pharmaceutical Preparations · L2 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $36.9M | $28.9M | $5.0M | $9.5M | $9.7M | $5.3M |
| Operating income | −$55.5M | −$48.5M | −$66.1M | −$79.5M | −$114.4M | −$73.8M |
| Net income | −$57.2M | −$49.5M | −$69.5M | −$82.8M | −$114.8M | −$74.4M |
| Total assets | $31.8M | $80.9M | $58.4M | $94.1M | $110.4M | $95.8M |
| Total liabilities | $28.5M | $27.6M | $25.3M | $52.8M | $41.8M | $13.7M |
| Equity | $3.3M | $53.4M | $33.1M | $41.3M | $68.6M | $82.1M |
| EPS (diluted) | $-21.32 | $-28.52 | $-135.23 | $-11.15 | — | — |
| Shares out. | 60.5M | 25.0M | 94.6M | 69.7M | 36.7M | 2.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −150.2%
- Net margin
- −154.8%
- Return on equity
- −1736.6%
- Return on assets
- −180.0%
- Return on capital (ROCE)
- −1333.9%
- Liabilities / assets
- 89.6%
- Debt / equity
- 8.65×
- Book value / share
- $0.05
- Revenue growth (YoY)
- 27.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -77.90distress
- Accruals / assets
- −64.5%clean
- Beneish M-Score
- -5.05normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2023
- NT 10-Qmissed a reporting deadline ↗May 15, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Director / officer change · Other material eventJul 31, 2023
- Delisting / listing-standard noticeJul 24, 2023
- Director / officer changeJul 7, 2023
- Delisting / listing-standard noticeJun 1, 2023
- Entered a material agreementFeb 6, 2023
- Director / officer changeJan 20, 2023
- Terminated a material agreement · Costs from exit or disposal · Other material eventJan 9, 2023
- Other material eventNov 28, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.